Generics, Not Reglan Cos., Had Duty To Warn: Judge

Law360, New York (March 17, 2009, 12:00 AM EDT) -- A federal judge has tossed Wyeth Inc. and Schwarz Pharma Inc. from a lawsuit alleging the brand-name pharmaceutical companies failed to warn that a copycat version of their anti-heartburn medicine Reglan could cause an incurable muscular disorder, but has ruled that, in light of the recent U.S. Supreme Court ruling in Wyeth v. Levine, the generic-drug makers must face the plaintiff's state law tort claims.

In a ruling March 11 in the U.S. District Court for the Western District of Oklahoma, Judge Vicki Miles-LaGrange denied motions...
To view the full article, register now.




Case Information

Case Title

Schrock et al v. Wyeth Inc et al

Case Number



Oklahoma Western

Nature of Suit

Personal Inj. Prod. Liability


Vicki Miles-LaGrange

Date Filed

April 30, 2008

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.